Takeaway

• In at-risk adults aged 40-75 years, statins for primary cardiovascular disease (CVD) prevention have moderate benefits, according to United States Preventive Services Task Force (USPSTF).
• Editorial criticizes “arbitrary” risk threshold:
  • This approach “[allows] atherosclerosis to proceed unchecked for decades.”
  • “It is time to realign statin guidelines with the biology of...